SV Atlas
← All founders
Yongjin Park

2x founder

Yongjin Park

Founder at 1849 bio (YC S24)

2024Founder· 1849 bio
Founder · since 2020
Company
1849 bio
Role
Founder, CSO
current
Stage
—
no public source
Raised
—
no public source
Based
San Francisco Bay Area
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
1849 bio logo
1849 bio

Engineering microbes for miners to unlock billions in trapped metal

Summer 2024

Experience

Career

  • 1849 bio logo

    1849 bio

    Founder

    Founder, CSO · San Francisco Bay Area · 2024 – Present

    2024
  • Pivot Bio logo

    Pivot Bio

    Scientist III, Technical Project Lead · Berkeley, California, United States · 2023 – 2024

    2023
  • Pivot Bio logo

    Pivot Bio

    Scientist II · Berkeley, California, United States · 2021 – 2023

    2021
  • Pivot Bio logo

    Pivot Bio

    Scientist I · Berkeley, California, United States · 2020 – 2021

    2020
  • Empress Therapeutics

    Founder

    Synthetic Biology Consultant · Cambridge, Massachusetts, United States · 2020 – 2022

    2020
  • Zymergen, Inc. logo

    Zymergen, Inc.

    Scientist I · Emeryville, California · 2019 – 2020

    2019
  • Massachusetts Institute of Technology logo

    Massachusetts Institute of Technology

    Postdoctoral Researcher · 2019

    2019
  • Massachusetts Institute of Technology logo

    Massachusetts Institute of Technology

    Ph.D. candidate · 500 Technology Sq · 2012 – 2019

    2012
  • Korea Advanced Institute of Science and Technology logo

    Korea Advanced Institute of Science and Technology

    Bachelor of Science · Daedeok-gu, Daejeon, Korea · 2008 – 2012

    2008
  • Harvard Medical School logo

    Harvard Medical School

    Research Assistant · Cambridge, Massachusetts, United States · 2010 – 2011

    2010

Bio

I am the co-founder and CSO of 1849 bio. I studied chemical engineering at KAIST and did my PhD at MIT in the Department of Biological Engineering. During my PhD, I developed core technology used in the world's first engineered probiotic that went into clinical trial. After completing PhD, I worked in deep biotech companies, developing microbial products that were administered to over 6M acres of farmland in the US (about the area of Belgium!).